Has Daniel Spoon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $57,502 in general payments to Daniel Spoon, MD across 233 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Spoon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Spoon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Spoon, MD

Interventional Cardiology · Missoula, MTNPI 1104021781

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $37,425 of the $57,502 with a category attached, or 65.1%. Medtronic accounts for 68.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $26,396 and has fallen 81.3% since, to $4,936 in 2025. Among interventional cardiology clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,502in general payments, 2019–2025

Across 233 payments — averaging $246.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$39K
Abbott$10K
Abiomed$7K
Boston Scientific$859
Edwards Lifesciences$241
Shockwave Medical, Inc$145
plus $227 from 6 others

$1,439,621in research payments, 2019–2025

Across 277 payments — averaging $5197.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$865K
Abbott$408K
Medtronic$166K
Abiomed$263

What the payments were for

Consulting fees$5,3759%
Speaking & faculty fees$37,42565%
Grants$2,3884%
Travel & lodging$5,64410%
Food & beverage$6,65812%
Education$120%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	96	$39,270
Abbott	69	$9,618
Abiomed	10	$7,141
Boston Scientific	36	$859
Edwards Lifesciences	10	$241
Shockwave Medical, Inc	4	$145
Corcym Inc	1	$87
Chiesi USA, Inc.	3	$47
Heartflow, Inc.	1	$32
Philips North America LLC	1	$26
Asahi Intecc USA, Inc.	1	$23
Regeneron Healthcare Solutions, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,502 in reported general payments places this provider in the 95th percentile of 22 interventional cardiology providers in Montana.

See all interventional cardiology providers in Montana →

Medicare billing

Part B allowed, 2024

$172,362

Medicare patients

283

Services billed

702

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	146	$1,707
Prasugrel Hcl	27	$1,149
Atorvastatin Calcium	76	$841
Metoprolol Succinate	15	$325
Isosorbide Mononitrate ErIsosorbide Mononitrate	13	$166
Nitroglycerin	14	$86

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Missoula

James MadduxMissoula$26K
Mark SanzMissoula$2K
Steven GoldbergGreat Falls$134K
Robert MinorBillings$46K
Michael EisenhauerGreat Falls$46K
Joshua VogtKalispell$41K
Claudia Lama von BuchwaldBillings$29K
Per SommerBillings$27K
Robert TerryBillings$12K
William HullButte$9K

See the full list for Montana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →